Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC/3TC/ZDV vs LPV/RTV/ZDV/3TC in Pregnancy
NCT00086359Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of abacavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Proportion of women with virologic suppression to less than 400 copies/ml. Started Jul 2004; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00086359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086359.